Hudson Bay Capital Management
UTHR icon

Hudson Bay Capital Management’s United Therapeutics UTHR Stock Holding History

Hudson Bay Capital Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.71M Sell
5,000
-15,918
-76% -$8.96M 0.01% 737
2026
Q1 		$12.4M Buy
+20,918
New +$10.4M 0.04% 273
2025
Q4 		– Sell
-21,524
Closed -$9.02M – 1543
2025
Q3 		$9.02M Sell
21,524
-18,823
-47% -$6.33M 0.03% 383
2025
Q2 		$11.6M Sell
40,347
-27,472
-41% -$8.21M 0.04% 327
2025
Q1 		$20.9M Sell
67,819
-2,500
-4% -$857K 0.06% 257
2024
Q4 		$24.8M Buy
70,319
+34,810
+98% +$12.8M 0.09% 222
2024
Q3 		$12.7M Buy
+35,509
New +$12M 0.05% 240
2024
Q2 		– Sell
-20,000
Closed -$5.29M – 949
2024
Q1 		$4.59M Buy
20,000
+8,900
+80% +$2.01M 0.03% 315
2023
Q4 		$2.44M Buy
+11,100
New +$2.56M 0.02% 415
2021
Q1 		– Sell
-10,000
Closed -$1.52M – 950
2020
Q4 		$1.52M Sell
10,000
-25,000
-71% -$3.28M 0.02% 423
2020
Q3 		$3.54M Buy
+35,000
New +$3.84M 0.05% 283
2020
Q2 		– Sell
-70,000
Closed -$6.64M – 572
2020
Q1 		$6.64M Sell
70,000
-30,000
-30% -$2.85M 0.17% 116
2019
Q4 		$8.81M Buy
+100,000
New +$8.8M 0.2% 97
2019
Q3 		– Sell
-15,000
Closed -$1.17M – 490
2019
Q2 		$1.17M Buy
+15,000
New +$1.4M 0.03% 318
2017
Q3 		– Sell
-50,200
Closed -$6.51M – 536
2017
Q2 		$6.51M Sell
50,200
-12,374
-20% -$1.54M 0.13% 148
2017
Q1 		$8.47M Buy
+62,574
New +$9.48M 0.11% 181

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Hudson Bay Capital Management's UTHR Position: Q2 2026 in Review

Hudson Bay Capital Management reduced its United Therapeutics (UTHR) stake by 76% in Q2 2026, selling an estimated $8.96M and leaving 5,000 shares worth $2.71M. The position accounts for 0.01% of the portfolio, ranked #737.

Hudson Bay Capital Management first reported a position in UTHR in Q1 2017 and has held it in 16 quarters since. The position peaked at $24.8M in Q4 2024. 878 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Hudson Bay Capital Management held 5,000 shares of United Therapeutics worth $2.71M as of Q2 2026.
  • Hudson Bay Capital Management sold 15,918 United Therapeutics shares in Q2 2026, an estimated $8.96M.
  • United Therapeutics made up 0.01% of Hudson Bay Capital Management's portfolio in Q2 2026, its #737 holding.
  • Hudson Bay Capital Management first reported a position in United Therapeutics in Q1 2017 and has held it in 16 quarters since.
  • Hudson Bay Capital Management's United Therapeutics position peaked at $24.8M in Q4 2024.
  • 878 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Hudson Bay Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.